Japan Tissue Engineered - Skin Substitute Procedures Outlook to 2024
Summary GlobalData’s new report, Japan Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Japan Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Scope - Japan Tissue Engineered - Skin Substitute Procedures volumes by segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. - Projections for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
Reasons to buy - Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future. - Develop market-entry and market expansion strategies.
Our reports have been used by over 10K customers, including:
406 pages •
By Global Industry Analysts
• Feb 2019
This report analyzes the worldwide markets for Incontinence and Ostomy Care Products in US$ Thousand by the following Product Segments: Incontinence Products (Disposable Adult Diapers, Disposable Adult Shields, Disposable Under Pads, Drainage Bags, Incontinence Clamps, Incontinence Cleaners, Deodorizers & Urinals), and Ostomy Products...
Summary Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc, is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.